Showing results (111-120 of 162) with videos related to

Sort By:
Pageof 17
Journal of Burn Care & Research : Official Publication of the American Burn Association|January 28, 2026
Treatment of friction injury using enzymatic debridement and autologous skin cell suspensionW Preston Hewgley, Jonathan Black, Jan O Jansen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2019
Purity Independent Subtyping of Tumors (PurIST), A Clinically Robust, Single-sample Classifier for Tumor Subtyping in Pancreatic CancerNaim U Rashid, Xianlu L Peng, Chong Jin, et al.
Elife|May 19, 2021
Single-cell transcriptome analysis defines heterogeneity of the murine pancreatic ductal treeAudrey M Hendley, Arjun A Rao, Laura Leonhardt, et al.
The Journal of Clinical Investigation|August 8, 2009
HIF2alpha cooperates with RAS to promote lung tumorigenesis in miceWilliam Y Kim, Samanthi Perera, Bing Zhou, et al.
Nature Communications|January 16, 2019
Tyrosyl phosphorylation of KRAS stalls GTPase cycle via alteration of switch I and II conformationYoshihito Kano, Teklab Gebregiworgis, Christopher B Marshall, et al.
American Journal of Surgery|March 3, 2020
Post-thyroidectomy emergency room visits and readmissions: Assessment from the Collaborative Endocrine Surgery Quality Improvement Program (CESQIP)Aida Taye, William B Inabnet, Stephanie Pan, et al.
Nature Genetics|September 8, 2015
Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinomaRichard A Moffitt, Raoud Marayati, Elizabeth L Flate, et al.
Plos Medicine|July 21, 2010
A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinomaJeran K Stratford, David J Bentrem, Judy M Anderson, et al.
Hepatology Communications|August 5, 2024
Pan-lysyl oxidase inhibition disrupts fibroinflammatory tumor stroma, rendering cholangiocarcinoma susceptible to chemotherapyPaul R Burchard, Luis I Ruffolo, Nicholas A Ullman, et al.
Cancer Cell|January 4, 2016
Long-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth SuppressionTikvah K Hayes, Nicole F Neel, Chaoxin Hu, et al.
Pageof 17